Schonfeld Strategic Advisors’s Amylyx Pharmaceuticals AMLX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.14M | Buy |
646,443
+529,303
| +452% | +$3.39M | 0.03% | 564 |
|
|
2025
Q1 | $415K | Sell |
117,140
-76,791
| -40% | -$272K | ﹤0.01% | 1540 |
|
|
2024
Q4 | $733K | Buy |
193,931
+27,502
| +17% | +$104K | ﹤0.01% | 1192 |
|
|
2024
Q3 | $539K | Buy |
166,429
+144,829
| +671% | +$469K | ﹤0.01% | 1266 |
|
|
2024
Q2 | $41K | Buy |
+21,600
| New | +$41K | ﹤0.01% | 1814 |
|
|
2023
Q4 | – | Sell |
-137,523
| Closed | -$2.52M | – | 1752 |
|
|
2023
Q3 | $2.52M | Sell |
137,523
-72,862
| -35% | -$1.33M | 0.02% | 652 |
|
|
2023
Q2 | $4.54M | Sell |
210,385
-74,620
| -26% | -$1.61M | 0.04% | 515 |
|
|
2023
Q1 | $8.36M | Buy |
285,005
+173,081
| +155% | +$5.08M | 0.08% | 328 |
|
|
2022
Q4 | $4.14M | Sell |
111,924
-213,776
| -66% | -$7.9M | 0.03% | 541 |
|
|
2022
Q3 | $9.17M | Buy |
+325,700
| New | +$9.17M | 0.08% | 340 |
|